Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$0.37 - $1.69 $92 - $422
-250 Reduced 0.8%
31,154 $24,000
Q2 2023

Aug 11, 2023

SELL
$0.39 - $1.69 $87 - $380
-225 Reduced 0.71%
31,404 $12,000
Q2 2022

Aug 08, 2022

SELL
$2.85 - $7.77 $57 - $155
-20 Reduced 0.06%
31,629 $90,000
Q1 2022

Apr 21, 2022

SELL
$5.7 - $9.3 $1,026 - $1,674
-180 Reduced 0.57%
31,649 $240,000
Q4 2021

Jan 31, 2022

SELL
$8.73 - $15.27 $4,993 - $8,734
-572 Reduced 1.77%
31,829 $278,000
Q3 2021

Nov 01, 2021

SELL
$13.52 - $23.95 $338 - $598
-25 Reduced 0.08%
32,401 $449,000
Q2 2021

Aug 06, 2021

SELL
$22.12 - $32.06 $8,604 - $12,471
-389 Reduced 1.19%
32,426 $784,000
Q1 2021

May 03, 2021

BUY
$26.12 - $52.17 $12,407 - $24,780
475 Added 1.47%
32,815 $1.05 Million
Q3 2020

Nov 12, 2020

SELL
$14.17 - $19.48 $5,880 - $8,084
-415 Reduced 1.27%
32,340 $463,000
Q2 2020

Aug 03, 2020

BUY
$13.25 - $21.72 $6,691 - $10,968
505 Added 1.57%
32,755 $529,000
Q1 2020

May 08, 2020

SELL
$9.73 - $24.9 $7,852 - $20,094
-807 Reduced 2.44%
32,250 $465,000
Q4 2019

Feb 05, 2020

BUY
$14.22 - $23.38 $6,754 - $11,105
475 Added 1.46%
33,057 $697,000
Q3 2019

Oct 29, 2019

BUY
$22.93 - $41.06 $4,861 - $8,704
212 Added 0.65%
32,582 $747,000
Q2 2019

Aug 05, 2019

BUY
$38.73 - $52.03 $20,449 - $27,471
528 Added 1.66%
32,370 $1.13 Million
Q1 2019

May 13, 2019

BUY
$28.11 - $50.77 $3,232 - $5,838
115 Added 0.36%
31,842 $1.38 Million
Q4 2018

Feb 12, 2019

SELL
$26.22 - $56.89 $2,622 - $5,689
-100 Reduced 0.31%
31,727 $853,000
Q3 2018

Nov 15, 2018

BUY
$24.31 - $52.74 $18,743 - $40,662
771 Added 2.48%
31,827 $1.18 Million
Q2 2018

Aug 08, 2018

BUY
$20.25 - $35.96 $628,884 - $1.12 Million
31,056 New
31,056 $910,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $3.05B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Sfmg, LLC Portfolio

Follow Sfmg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sfmg, LLC with notifications on news.